Angel Basilio Corredor-Quintero
Angel Basilio Corredor-Quintero has a total of 451 co-authors. Here are the top co-authors by number of shared publications:
- Leonardo Augusto Carbonera
Hospital Moinhos de Vento
4 shared publications - Matías Javier Alet
Departamento de Neurología Vascular, Centro Integral de Neurología Vascular, Fleni, Ciudad Autónoma de Buenos Aires, Argentina
4 shared publications - Pablo Amaya
Fundación Valle del Lili
4 shared publications - Vanessa Cano-Nigenda
Stroke Clinic, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suarez, Mexico City, Mexico
4 shared publications - Alejandro A. Rabinstein
From the Department of Neurology, Mayo Clinic, Rochester, MN
3 shared publications - Antonio Bernabe-Ortiz
CRONICAS Centre of Excellence in Chronic Diseases Universidad Peruana Cayetano Heredia Lima Peru
3 shared publications
Latest Publications
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e047114
Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021
Background: Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. Methods: Using GBD (Global Burden of Disease) study 2021 data, we analyzed stroke mortality and disability‐adjusted life‐year (DALY) rates attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Age‐standardized rates were compared by sex, stroke subtype, region, and Socio‐Demographic Index; age‐specific estimates used 5‐year groups (25–95+ years). Trends were assessed using average annual percentage change (AAPC) from Joinpoint regression. Results: In 2021, 78.8% (95% uncertainty interval, 70.1%–85.9%) of stroke deaths and 76.9% (68.2%–83.6%) of DALYs were attributable to the 23 risk factors combined. High systolic blood pressure was the leading contributor, accounting for 20.87 attributable deaths (95% uncertainty interval, 15.17–25.80) and 453.30 DALYs (333.16–556.41) per 100 000, representing 54.8% of deaths and 52.2% of DALYs. From 1990 to 2021, the largest reductions occurred for household air pollution from solid fuels (deaths AAPC, −5.09% [95% CI, −5.17 to −5.02]; DALYs AAPC, −4.92% [−4.98 to −4.86]) and secondhand smoke (deaths AAPC, −3.45% [−3.49 to −3.41]). Reductions were minimal for high body mass index (deaths AAPC, −0.54% [−0.59 to −0.49]; DALYs AAPC, −0.42% [−0.46 to −0.37]), high fasting plasma glucose (deaths AAPC, −1.10% [−1.14 to −1.06]), and dietary risks; high body mass index burden increased in the Caribbean, notably in Haiti and the Dominican Republic. Stroke deaths attributable to high temperature increased >3.5% annually (AAPC) in Panama, Jamaica, and the Dominican Republic. High systolic blood pressure burden remained highly unequal, with age‐standardized death rates of 10.42 per 100 000 in high–Socio‐Demographic Index versus 109.33 in low–Socio‐Demographic Index countries. Conclusions: Stroke burden attributable to modifiable risk factors declined overall, but marked disparities persisted. High systolic blood pressure remained dominant, whereas stalled or increasing burden from obesity, metabolic, and dietary risks highlights the need for equity‐focused prevention across the Americas.
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19) , e047114
Stroke Burden Attributable to Risk Factors in the Americas, 1990 to 2021: A Temporal Trends Analysis From the GBD Study 2021
Background: Stroke burden varies across the Americas, yet data on modifiable risk factor contributions remain limited. Methods: Using GBD (Global Burden of Disease) study 2021 data, we analyzed stroke mortality and disability‐adjusted life‐year (DALY) rates attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Age‐standardized rates were compared by sex, stroke subtype, region, and Socio‐Demographic Index; age‐specific estimates used 5‐year groups (25–95+ years). Trends were assessed using average annual percentage change (AAPC) from Joinpoint regression. Results: In 2021, 78.8% (95% uncertainty interval, 70.1%–85.9%) of stroke deaths and 76.9% (68.2%–83.6%) of DALYs were attributable to the 23 risk factors combined. High systolic blood pressure was the leading contributor, accounting for 20.87 attributable deaths (95% uncertainty interval, 15.17–25.80) and 453.30 DALYs (333.16–556.41) per 100 000, representing 54.8% of deaths and 52.2% of DALYs. From 1990 to 2021, the largest reductions occurred for household air pollution from solid fuels (deaths AAPC, −5.09% [95% CI, −5.17 to −5.02]; DALYs AAPC, −4.92% [−4.98 to −4.86]) and secondhand smoke (deaths AAPC, −3.45% [−3.49 to −3.41]). Reductions were minimal for high body mass index (deaths AAPC, −0.54% [−0.59 to −0.49]; DALYs AAPC, −0.42% [−0.46 to −0.37]), high fasting plasma glucose (deaths AAPC, −1.10% [−1.14 to −1.06]), and dietary risks; high body mass index burden increased in the Caribbean, notably in Haiti and the Dominican Republic. Stroke deaths attributable to high temperature increased >3.5% annually (AAPC) in Panama, Jamaica, and the Dominican Republic. High systolic blood pressure burden remained highly unequal, with age‐standardized death rates of 10.42 per 100 000 in high–Socio‐Demographic Index versus 109.33 in low–Socio‐Demographic Index countries. Conclusions: Stroke burden attributable to modifiable risk factors declined overall, but marked disparities persisted. High systolic blood pressure remained dominant, whereas stalled or increasing burden from obesity, metabolic, and dietary risks highlights the need for equity‐focused prevention across the Americas.
- Open Access
Stroke Burden Attributable to Risk Factors in the Americas, 1990–2021: A Temporal Trends Analysis from the Global Burden of Disease Study 2021
Background: Stroke remains a major public health concern with marked disparities across populations, particularly in the Americas. Despite documented declines in overall burden, limited data exist on how modifiable risk factors contribute to contemporary stroke trends across the continent. Methods: Using data from the Global Burden of Disease 2021 study, we analyzed age- standardized mortality rates and age-standardized disability-adjusted life-years (DALYs) rates from stroke attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Estimates were stratified by age, sex, stroke subtype, and Socio-Demographic Index (SDI). Temporal trends from 1990 to 2021 were assessed using the average annual percent change (AAPC), which was estimated applying Joinpoint regression analysis. Results: In 2021, 78% of stroke deaths and 77% of stroke DALYs were attributable to modifiable risk factors in the Americas. High systolic blood pressure was the leading risk factor (20.87 deaths [95% uncertainty interval: 15.17–25.8] and 453.30 DALYs [333.16–556.41] per 100,000), contributing over half of stroke burden. From 1990–2021, the largest reductions occurred in household air pollution (deaths AAPC −5.09% [−5.17–−5.02]; DALYs AAPC −4.92% [−4.98–−4.86]) and secondhand smoke (deaths AAPC −3.45% [−3.49–−3.41]; DALYs AAPC −3.37% [−3.41–−3.33]). In contrast, several risk factors showed minimal progress: high body-mass index (deaths AAPC −0.54% [−0.59–−0.49]; DALYs AAPC −0.42% [−0.46–−0.37]) and high fasting glucose (deaths AAPC −1.10% [−1.14–−1.06]; DALYs AAPC −0.99% [−1.05–−0.93]). High temperature demonstrated increases, with AAPCs exceeding +3.5% in select countries. High systolic blood pressure declined moderately (deaths AAPC −1.89% [−1.93–−1.85]; DALYs AAPC −1.84% [−1.89–−1.80]), with stroke burden remaining disproportionately higher in low-SDI countries. Conclusion: Although encouraging declines in stroke burden attributable to risk factors have been observed over three decades, substantial variation persists by geography and SDI. High systolic blood pressure remains the leading modifiable risk factor. Minimal progress in obesity and metabolic factors highlights the need for equity-focused strategies to address persistent and emerging stroke risks across the Americas.
Open AccessStroke Burden Attributable to Risk Factors in the Americas, 1990–2021: A Temporal Trends Analysis from the Global Burden of Disease Study 2021
Background: Stroke remains a major public health concern with marked disparities across populations, particularly in the Americas. Despite documented declines in overall burden, limited data exist on how modifiable risk factors contribute to contemporary stroke trends across the continent. Methods: Using data from the Global Burden of Disease 2021 study, we analyzed age- standardized mortality rates and age-standardized disability-adjusted life-years (DALYs) rates from stroke attributable to 23 modifiable risk factors across 39 countries and territories in the Americas. Estimates were stratified by age, sex, stroke subtype, and Socio-Demographic Index (SDI). Temporal trends from 1990 to 2021 were assessed using the average annual percent change (AAPC), which was estimated applying Joinpoint regression analysis. Results: In 2021, 78% of stroke deaths and 77% of stroke DALYs were attributable to modifiable risk factors in the Americas. High systolic blood pressure was the leading risk factor (20.87 deaths [95% uncertainty interval: 15.17–25.8] and 453.30 DALYs [333.16–556.41] per 100,000), contributing over half of stroke burden. From 1990–2021, the largest reductions occurred in household air pollution (deaths AAPC −5.09% [−5.17–−5.02]; DALYs AAPC −4.92% [−4.98–−4.86]) and secondhand smoke (deaths AAPC −3.45% [−3.49–−3.41]; DALYs AAPC −3.37% [−3.41–−3.33]). In contrast, several risk factors showed minimal progress: high body-mass index (deaths AAPC −0.54% [−0.59–−0.49]; DALYs AAPC −0.42% [−0.46–−0.37]) and high fasting glucose (deaths AAPC −1.10% [−1.14–−1.06]; DALYs AAPC −0.99% [−1.05–−0.93]). High temperature demonstrated increases, with AAPCs exceeding +3.5% in select countries. High systolic blood pressure declined moderately (deaths AAPC −1.89% [−1.93–−1.85]; DALYs AAPC −1.84% [−1.89–−1.80]), with stroke burden remaining disproportionately higher in low-SDI countries. Conclusion: Although encouraging declines in stroke burden attributable to risk factors have been observed over three decades, substantial variation persists by geography and SDI. High systolic blood pressure remains the leading modifiable risk factor. Minimal progress in obesity and metabolic factors highlights the need for equity-focused strategies to address persistent and emerging stroke risks across the Americas.
- Open Access
- 2 July 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (3)
Deficiencies in infrastructure for the diagnosis and treatment of stroke in Colombia
The lack of access to reperfusion therapies for nearly 10% of Colombia’s population has a significant impact on disability rates, quality-adjusted life years lost, productive years lost, and stroke-related mortality. This diagnosis poses critical challenges: Adherence to health system principles: Efficiency, universality, comprehensiveness, unity, solidarity, and participation. Each principle is compromised to varying degrees by the absence of infrastructure in affected regions (4). Brain health as a development priority: The relationship between brain health, productivity, and quality of life is well established (5). The lack of access to standard treatment for one of the most disabling neurological diseases perpetuates a vicious cycle of illness, poverty, and limited development. Public policy formulation: Colombia faces the complex challenge of legislating and creating public policies that address the needs of both urban populations and those in remote, rural, and insular areas, guaranteeing equal rights to health services for all Colombians (6). In conclusion, Colombia faces significant deficiencies in basic stroke treatment infrastructure ¾especially in underserved regions¾ a low rate of certified stroke centers, a substantial proportion of patients who would remain untreated in the event of a stroke, and a grave threat to brain health and human development. The most affected geographic regions are the Orinoco, Amazon, and Pacific areas. We call upon the Ministry of Health, municipal and departmental authorities, scientific societies, insurers, and health care providers to take appropriate measures, within their respective mandates, to guarantee access to stroke treatment for populations in these regions.
- 2 July 2025
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 41 (3)
Open AccessDeficiencies in infrastructure for the diagnosis and treatment of stroke in Colombia
The lack of access to reperfusion therapies for nearly 10% of Colombia’s population has a significant impact on disability rates, quality-adjusted life years lost, productive years lost, and stroke-related mortality. This diagnosis poses critical challenges: Adherence to health system principles: Efficiency, universality, comprehensiveness, unity, solidarity, and participation. Each principle is compromised to varying degrees by the absence of infrastructure in affected regions (4). Brain health as a development priority: The relationship between brain health, productivity, and quality of life is well established (5). The lack of access to standard treatment for one of the most disabling neurological diseases perpetuates a vicious cycle of illness, poverty, and limited development. Public policy formulation: Colombia faces the complex challenge of legislating and creating public policies that address the needs of both urban populations and those in remote, rural, and insular areas, guaranteeing equal rights to health services for all Colombians (6). In conclusion, Colombia faces significant deficiencies in basic stroke treatment infrastructure ¾especially in underserved regions¾ a low rate of certified stroke centers, a substantial proportion of patients who would remain untreated in the event of a stroke, and a grave threat to brain health and human development. The most affected geographic regions are the Orinoco, Amazon, and Pacific areas. We call upon the Ministry of Health, municipal and departmental authorities, scientific societies, insurers, and health care providers to take appropriate measures, within their respective mandates, to guarantee access to stroke treatment for populations in these regions.
- Open Access
- 15 February 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 43, 101017
Risk and impact of stroke across 38 countries and territories of the Americas from 1990 to 2021: a population-based trends analysis from the Global Burden of Disease Study 2021
- 15 February 2025
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 43, 101017
Open AccessRisk and impact of stroke across 38 countries and territories of the Americas from 1990 to 2021: a population-based trends analysis from the Global Burden of Disease Study 2021
- Open Access
- 3 July 2023
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 53 (2) , 233-238
Regional Initiatives to Empower Young Medical Doctors: The Young Stroke Latin American Task Force
Local and regional cooperation may strengthen efforts to reduce stroke burden in low-resource settings. New generations full of energy, honoring the past achievements of mentors and current stroke leaders, have the potential to stimulate stroke research, and prevention and implement the available evidence-based treatments. This article presents how a local initiative focused on young stroke professionals may promote comprehensive stroke care in the region. We will present the creation of ALATAC, its main purpose and objectives, the structure organization, the committees, ongoing activities, the potential results to be achieved, and how to become a member of this group.
- 3 July 2023
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 53 (2) , 233-238
Open AccessRegional Initiatives to Empower Young Medical Doctors: The Young Stroke Latin American Task Force
Local and regional cooperation may strengthen efforts to reduce stroke burden in low-resource settings. New generations full of energy, honoring the past achievements of mentors and current stroke leaders, have the potential to stimulate stroke research, and prevention and implement the available evidence-based treatments. This article presents how a local initiative focused on young stroke professionals may promote comprehensive stroke care in the region. We will present the creation of ALATAC, its main purpose and objectives, the structure organization, the committees, ongoing activities, the potential results to be achieved, and how to become a member of this group.
- Open Access
- 24 June 2023
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 39 (2)
Degeneración combinada subaguda
Introducción: la degeneración combinada subaguda (DCS) es un trastorno caracterizado por la degeneración difusa de la sustancia blanca a nivel del SNC, que afecta específicamente los cordones posteriores y laterales de la médula espinal, con pérdida de la mielinización periférica y central. De manera frecuente, las manifestaciones clínicas son parestesias y debilidad generalizada causada por deficiencia de vitamina B12. Presentación del caso: paciente masculino de 79 años, con cuadro clínico de 3 meses de evolución de limitación funcional para la marcha acompañado de desorientación. Al examen físico evidenció desorientación, cuadriparesia e hiporreflexia, con niveles séricos bajos de vitamina B12, RM cervical con focos hiperintensos en el segmento C3/C6 y endoscopia de vías digestivas altas con atrofia de la mucosa gástrica. Presentamos un caso clínico de DCS. Discusión: este es un caso de DCS que se manifiesta por medio de una alteración neuropsiquiátrica, con una presentación inicial inespecífica que comprende deterioro de la marcha, movimientos anormales con afectación cognitiva y psiquiátrica dada por alucinaciones visuales y desorientación. Su sospecha es importante en pacientes con factores de riesgo por medio del conocimiento de la patología, para una adecuada sospecha diagnóstica y una instauración oportuna de reposición vitamínica, la cual presenta una excelente respuesta. Conclusión: la DCS es un trastorno en el que se evidencia anemia con deficiencia de vitamina B12, desmielinización del tejido nervioso y en muchos casos signos sugestivos de atrofia gástrica, y para ello es cual es crucial la detección temprana de esta enfermedad por medio de la determinación de niveles séricos de vitamina B12, asociado a síntomas neurológicos, para así lograr su adecuado diagnóstico y tratamiento.
- 24 June 2023
- Published by Asociacion Colombiana de Neurologia in Acta Neurológica Colombiana
- Vol. 39 (2)
Open AccessDegeneración combinada subaguda
Introducción: la degeneración combinada subaguda (DCS) es un trastorno caracterizado por la degeneración difusa de la sustancia blanca a nivel del SNC, que afecta específicamente los cordones posteriores y laterales de la médula espinal, con pérdida de la mielinización periférica y central. De manera frecuente, las manifestaciones clínicas son parestesias y debilidad generalizada causada por deficiencia de vitamina B12. Presentación del caso: paciente masculino de 79 años, con cuadro clínico de 3 meses de evolución de limitación funcional para la marcha acompañado de desorientación. Al examen físico evidenció desorientación, cuadriparesia e hiporreflexia, con niveles séricos bajos de vitamina B12, RM cervical con focos hiperintensos en el segmento C3/C6 y endoscopia de vías digestivas altas con atrofia de la mucosa gástrica. Presentamos un caso clínico de DCS. Discusión: este es un caso de DCS que se manifiesta por medio de una alteración neuropsiquiátrica, con una presentación inicial inespecífica que comprende deterioro de la marcha, movimientos anormales con afectación cognitiva y psiquiátrica dada por alucinaciones visuales y desorientación. Su sospecha es importante en pacientes con factores de riesgo por medio del conocimiento de la patología, para una adecuada sospecha diagnóstica y una instauración oportuna de reposición vitamínica, la cual presenta una excelente respuesta. Conclusión: la DCS es un trastorno en el que se evidencia anemia con deficiencia de vitamina B12, desmielinización del tejido nervioso y en muchos casos signos sugestivos de atrofia gástrica, y para ello es cual es crucial la detección temprana de esta enfermedad por medio de la determinación de niveles séricos de vitamina B12, asociado a síntomas neurológicos, para así lograr su adecuado diagnóstico y tratamiento.
- 24 January 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (4) , e408-e421
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events
Background and Objectives Declines in stroke admission, IV thrombolysis (IVT), and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the effect of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), IVT, and mechanical thrombectomy over a 1-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). Methods We conducted a longitudinal retrospective study across 6 continents, 56 countries, and 275 stroke centers. We collected volume data for COVID-19 admissions and 4 stroke metrics: ischemic stroke admissions, ICH admissions, IVT treatments, and mechanical thrombectomy procedures. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 148,895 stroke admissions in the 1 year immediately before compared with 138,453 admissions during the 1-year pandemic, representing a 7% decline (95% CI [95% CI 7.1–6.9]; p < 0.0001). ICH volumes declined from 29,585 to 28,156 (4.8% [5.1–4.6]; p < 0.0001) and IVT volume from 24,584 to 23,077 (6.1% [6.4–5.8]; p < 0.0001). Larger declines were observed at high-volume compared with low-volume centers (all p < 0.0001). There was no significant change in mechanical thrombectomy volumes (0.7% [0.6–0.9]; p = 0.49). Stroke was diagnosed in 1.3% [1.31–1.38] of 406,792 COVID-19 hospitalizations. SARS-CoV-2 infection was present in 2.9% ([2.82–2.97], 5,656/195,539) of all stroke hospitalizations. Discussion There was a global decline and shift to lower-volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared with the prior year. Mechanical thrombectomy volumes were preserved. These results suggest preservation in the stroke care of higher severity of disease through the first pandemic year. Trial Registration Information This study is registered under NCT04934020.
- 24 January 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (4) , e408-e421
Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events
Background and Objectives Declines in stroke admission, IV thrombolysis (IVT), and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the effect of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), IVT, and mechanical thrombectomy over a 1-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). Methods We conducted a longitudinal retrospective study across 6 continents, 56 countries, and 275 stroke centers. We collected volume data for COVID-19 admissions and 4 stroke metrics: ischemic stroke admissions, ICH admissions, IVT treatments, and mechanical thrombectomy procedures. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 148,895 stroke admissions in the 1 year immediately before compared with 138,453 admissions during the 1-year pandemic, representing a 7% decline (95% CI [95% CI 7.1–6.9]; p < 0.0001). ICH volumes declined from 29,585 to 28,156 (4.8% [5.1–4.6]; p < 0.0001) and IVT volume from 24,584 to 23,077 (6.1% [6.4–5.8]; p < 0.0001). Larger declines were observed at high-volume compared with low-volume centers (all p < 0.0001). There was no significant change in mechanical thrombectomy volumes (0.7% [0.6–0.9]; p = 0.49). Stroke was diagnosed in 1.3% [1.31–1.38] of 406,792 COVID-19 hospitalizations. SARS-CoV-2 infection was present in 2.9% ([2.82–2.97], 5,656/195,539) of all stroke hospitalizations. Discussion There was a global decline and shift to lower-volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared with the prior year. Mechanical thrombectomy volumes were preserved. These results suggest preservation in the stroke care of higher severity of disease through the first pandemic year. Trial Registration Information This study is registered under NCT04934020.
- Open Access
- 13 January 2022
- Published by Sociedad Medica Ecuatoriana de Neurologia in Revista Ecuatoriana de Neurologia
- Vol. 30 (3) , 18-25
Drip and ship: Una práctica usual en el tratamiento de ictus isquémico por oclusión de arterias proximales en países de altos ingresos pero anecdótica en Colombia
- 13 January 2022
- Published by Sociedad Medica Ecuatoriana de Neurologia in Revista Ecuatoriana de Neurologia
- Vol. 30 (3) , 18-25
Open AccessDrip and ship: Una práctica usual en el tratamiento de ictus isquémico por oclusión de arterias proximales en países de altos ingresos pero anecdótica en Colombia